Table 1 Clinical characteristics and MPS findings according to the presence or absence of a post-stress LVEF drop ≥5%
|  | LVEF drop (n = 167) | No LVEF drop (n = 517) | p-value |
|---|---|---|---|
Age (years) | 64 ± 10 | 63 ± 9 | 0.26 |
Male gender, n (%) | 110 (66%) | 351 (68%) | 0.62 |
Diabetes duration (months) | 127 ± 111 | 117 ± 112 | 0.35 |
Oral treatment, n (%) | 92 (55%) | 268 (52%) | 0.47 |
Insulin and oral, n (%) | 51 (31%) | 165 (32%) | 0.74 |
Insulin, n (%) | 24 (14%) | 84 (16%) | 0.56 |
Statin, n (%) | 32 (19%) | 91 (18%) | 0.65 |
Hypertension, n (%) | 128 (77%) | 381 (74%) | 0.44 |
Dyslipidemia, n (%) | 98 (59%) | 293 (57%) | 0.64 |
Smoking, n (%) | 67 (40%) | 210 (41%) | 0.81 |
Family history of CAD, n (%) | 56 (34%) | 178 (34%) | 0.83 |
Prior myocardial infarction, n (%) | 70 (42%) | 198 (38%) | 0.58 |
Exercise stress test, n (%) | 88 (53%) | 292 (56%) | 0.39 |
Summed stress score | 8.2 ± 8.2 | 6.7 ± 7.4 | <0.05 |
Summed rest score | 3.9 ± 5.6 | 4.1 ± 5.9 | 0.55 |
Summed difference score | 4.3 ± 5.1 | 2.5 ± 3.1 | <0.001 |
Rest LVEF (%) | 60 ± 12 | 54 ± 14 | <0.001 |
Post-stress LVEF (%) | 52 ± 12 | 55 ± 14 | <0.01 |
Rest EDV (ml) | 95 ± 39 | 101 ± 46 | 0.13 |
Post-stress EDV (ml) | 98 ± 41 | 102 ± 46 | 0.37 |
Rest ESV (ml) | 42 ± 27 | 50 ± 38 | <0.05 |
Post-stress ESV (ml) | 51 ± 32 | 50 ± 39 | 0.80 |